These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9519755)

  • 1. Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases.
    Kowluru RA; Jirousek MR; Stramm L; Farid N; Engerman RL; Kern TS
    Diabetes; 1998 Mar; 47(3):464-9. PubMed ID: 9519755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.
    Koya D; Jirousek MR; Lin YW; Ishii H; Kuboki K; King GL
    J Clin Invest; 1997 Jul; 100(1):115-26. PubMed ID: 9202063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of retinal metabolism in diabetes or galactosemia: ATPases and glutathione.
    Kern TS; Kowluru RA; Engerman RL
    Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):2962-7. PubMed ID: 8206713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. VI. Comparison of retinal and cerebral cortex metabolism, and effects of antioxidant therapy.
    Kowluru RA; Engerman RL; Kern TS
    Free Radic Biol Med; 1999 Feb; 26(3-4):371-8. PubMed ID: 9895229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats.
    Bursell SE; Takagi C; Clermont AC; Takagi H; Mori F; Ishii H; King GL
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2711-20. PubMed ID: 9418723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants.
    Kowluru RA; Kern TS; Engerman RL; Armstrong D
    Diabetes; 1996 Sep; 45(9):1233-7. PubMed ID: 8772728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
    Ottlecz A; Bensaoula T
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of retinal metabolism in diabetes or galactosemia. II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy.
    Kowluru R; Kern TS; Engerman RL
    Curr Eye Res; 1994 Dec; 13(12):891-6. PubMed ID: 7720397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKC-beta inhibitor (LY333531) attenuates leukocyte entrapment in retinal microcirculation of diabetic rats.
    Nonaka A; Kiryu J; Tsujikawa A; Yamashiro K; Miyamoto K; Nishiwaki H; Honda Y; Ogura Y
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2702-6. PubMed ID: 10937586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated.
    Kowluru RA
    Acta Diabetol; 2001 Dec; 38(4):179-85. PubMed ID: 11855796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine.
    Kowluru RA; Engerman RL; Kern TS
    Curr Eye Res; 2000 Oct; 21(4):814-9. PubMed ID: 11120572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the mechanism for the inhibition of Na+,K(+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2.
    Xia P; Kramer RM; King GL
    J Clin Invest; 1995 Aug; 96(2):733-40. PubMed ID: 7635966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat.
    Kowluru RA
    Curr Eye Res; 2002 Feb; 24(2):123-8. PubMed ID: 12187484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained recovery of Na(+)-K(+)-ATPase activity in sciatic nerve of diabetic mice by administration of H7 or calphostin C, inhibitors of PKC.
    Hermenegildo C; Felipo V; Miñana MD; Romero FJ; Grisolía S
    Diabetes; 1993 Feb; 42(2):257-62. PubMed ID: 7678826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.
    Nakamura J; Kato K; Hamada Y; Nakayama M; Chaya S; Nakashima E; Naruse K; Kasuya Y; Mizubayashi R; Miwa K; Yasuda Y; Kamiya H; Ienaga K; Sakakibara F; Koh N; Hotta N
    Diabetes; 1999 Oct; 48(10):2090-5. PubMed ID: 10512378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.
    Ottlecz A; Bensaoula T; Eichberg J; Peterson RG
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2157-64. PubMed ID: 8843902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo phosphorylation of the Na,K-ATPase alpha subunit in sciatic nerves of control and diabetic rats: effects of protein kinase modulators.
    Borghini I; Geering K; Gjinovci A; Wollheim CB; Pralong WF
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6211-5. PubMed ID: 8016140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and ultrastructural studies in the neural retina and retinal pigment epithelium of STZ-diabetic rats: effect of captopril.
    Bensaoula T; Ottlecz A
    J Ocul Pharmacol Ther; 2001 Dec; 17(6):573-86. PubMed ID: 11777181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKC-beta and PKC-zeta mediate opposing effects on proximal tubule Na+,K+-ATPase activity.
    Efendiev R; Bertorello AM; Pedemonte CH
    FEBS Lett; 1999 Jul; 456(1):45-8. PubMed ID: 10452527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor.
    Ishii H; Jirousek MR; Koya D; Takagi C; Xia P; Clermont A; Bursell SE; Kern TS; Ballas LM; Heath WF; Stramm LE; Feener EP; King GL
    Science; 1996 May; 272(5262):728-31. PubMed ID: 8614835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.